Market Definition

In-vitro tests are a cost-effective and time-saving way to get toxicity information. Rapid advancements in biomedical sciences are expected to lead to the development of newer and more advanced in-vitro hazard characterisation test methodologies. Toxicity testing is gradually getting more sophisticated, thanks to the use of new technologies. It is now in a position to benefit from promising biotechnology revolutions. With advancements in biotechnology, the demand for toxicity testing is expected to rise. Bioinformatics, computational toxicology, epigenetics, and other improvements in toxicity testing methodologies have the ability to alter the paradigm from whole-animal testing to in-vitro methods that examine changes in multiple processes using cell lines and other biological components.

Elements such as over the projection period, regulatory bodies' reluctance to explore alternative approaches for providing safety and efficacy is likely to stifle global market growth. Across a variety of industries, there has been a growing emphasis on the development and application of non-animal testing methods. In addition to in vivo experiments, regulatory agencies can use proven alternative assays. In this case, in vitro approaches must demonstrate that they are safer and more effective than animal methods.

However, even after the assay has demonstrated its superior scientific relevance, a number of countries have exhibited a reluctance to use in vitro testing over in vivo procedures. Animal-test data is still used by a number of regulatory authorities in the United States. For the evaluation of new toxicity test methods, many agencies use in vivo techniques. The results of novel alternative approaches are compared to the results of animal tests in terms of quality.

The In-vitro Toxicology Testing market report provides geographic analysis covering regions, such as North America, Europe, Asia Pacific, and Rest of the World. The  In-vitro Toxicology Testing market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Report Scope

The global market report scope consists of a comprehensive study covering primary factors impacting the industry trends. The study includes analysis of regional and country-level market dynamics. The scope also consists of competitive overview offering company market shares coupled with company profiles for key revenue contributing companies. The report scope covers a detailed competitive outlook covering market shares and profiles of key participants in the market share.

Major Market Players

This report offers the major market player’s profiles, such as  Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).

The In-vitro Toxicology Testing Market report has been categorized as below

By Product & Service

  • Covid Impact,By Product & Service

  • Consumables

  • Assays

    • Bacterial Toxicity Assays

    • Enzyme Toxicity Assays

    • Cell-based Elisa & Western Blots

    • Receptor-binding Assays

    • Tissue Culture Assays

    • Other Assays

  • Equipment

  • Software

  • Services

By Method

  • Cellular Assays 

  • Biochemical Assays

  • In Silico Models

  • Ex Vivo Models

By Toxicity Endpoint & Test

  • ADME

  • Skin Irritation, Corrosion, & Sensitization

  • Genotoxicity Testing

  • Cytotoxicity Testing

  • Ocular Toxicity

  • Organ Toxicity

  • Phototoxicity Testing

  • Dermal Toxicity

  • Other Toxicity Endpoints & Tests

By Industry

  • Covid Impact,By Industry

  • Pharmaceuticals & Biopharmaceuticals

  • Cosmetic & Household Products

  • Food

  • Chemicals

By Technology

  • Cell Culture Technologies 

  • High-throughput Technologies 

  • Toxicogenomics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year – 2022
  • Forecast period - 2021 to 2027

Key Questions Addressed by the Report

  • New products/service competitors are exploring?
  • Key players in the In-vitro Toxicology Testing Market and how extreme is the competition?
  • What are the future market trends that manufacturers are emphasizing on in the future updates?
  • For each segment, what are the crucial opportunities in the market?
  • What are the key growth strategies embraced by key market players in the market?
  • What are the key success strategies adopted by major competitors in the market?

Why Buy this Report:

  • Obtain comprehensive insights on the In-vitro Toxicology Testing market trends
  • Note comprehensive analysis of the market status
  • Identifies the market opportunities and growth segments
  • Assessing business segments & product portfolios, and explain competitive dynamics
  • Provide strategy planning and industry dynamics to strengthen decision making

Report Content

1. Global In-vitro Toxicology Testing Market Introduction

1.1. Key Insights

1.2. Report Overview

1.3. Markets Covered

1.4. Stakeholders

2. Research Methodology

2.1. Research Scope

2.2. Market Research Process

2.3. Research Data Analysis

2.4. Market Size Estimation

3. Executive Summary 

4. Market Overview

4.1. Introduction

4.1. Market Drivers and Restraints

5. By Product & Service

    5.1.  Covid Impact,By Product & Service

    5.2.  Consumables

    5.3. Assays

        5.3.1. Bacterial Toxicity Assays

        5.3.2. Enzyme Toxicity Assays

        5.3.3. Cell-based Elisa & Western Blots

        5.3.4. Receptor-binding Assays

        5.3.5. Tissue Culture Assays

        5.3.6. Other Assays

    5.4. Equipment

    5.5. Software

    5.6. Services

6. By Method

6.1.  Cellular Assays 

6.2.  Biochemical Assays

6.3. In Silico Models

6.4. Ex Vivo Models

7. By Toxicity Endpoint & Test

7.1. ADME

7.2.  Skin Irritation, Corrosion, & Sensitization

7.3. Genotoxicity Testing

7.4. Cytotoxicity Testing

7.5. Ocular Toxicity

7.6. Organ Toxicity

7.7. Phototoxicity Testing

7.8. Dermal Toxicity

7.9. Other Toxicity Endpoints & Tests

8. By Industry

8.1. Covid Impact,By Industry

8.2.  Pharmaceuticals & Biopharmaceuticals

8.3. Cosmetic & Household Products

8.4. Food

8.5. Chemicals

9. By Technology

9.1. Cell Culture Technologies 

9.2.  High-throughput Technologies 

9.3. Toxicogenomics

10. By Region

10.1. Key Points

10.2. North America

10.3. Europe

10.4. Asia Pacific

10.5. Rest of the World

11. Company Profile

(Profile contain company overview, products/services, financials & recent developments)

11.1. Thermo Fisher Scientific Inc. (US)

11.2. Covance (US)

11.3. Bio-Rad Laboratories, Inc. (US)

11.4. GE Healthcare (US)

11.5. Eurofins Scientific SE (Luxembourg)

11.6. Merck KGaA (Germany)

11.7. Charles River Laboratories International, Inc. (US)

11.8. Catalent, Inc. (US)

11.9. Cyprotex (UK)

11.10. SGS S.A. (Switzerland)

11.11. QIAGEN N.V. (Germany)

11.12. Promega Corporation (US)

10.13. Gentronix Limited (UK)

10.14. BioIVT (US)

10.15. MB Research Laboratories (US)

The In-vitro Toxicology Testing Market report has been categorized as below

By Product & Service

  • Covid Impact,By Product & Service

  • Consumables

  • Assays

    • Bacterial Toxicity Assays

    • Enzyme Toxicity Assays

    • Cell-based Elisa & Western Blots

    • Receptor-binding Assays

    • Tissue Culture Assays

    • Other Assays

  • Equipment

  • Software

  • Services

By Method

  • Cellular Assays 

  • Biochemical Assays

  • In Silico Models

  • Ex Vivo Models

By Toxicity Endpoint & Test

  • ADME

  • Skin Irritation, Corrosion, & Sensitization

  • Genotoxicity Testing

  • Cytotoxicity Testing

  • Ocular Toxicity

  • Organ Toxicity

  • Phototoxicity Testing

  • Dermal Toxicity

  • Other Toxicity Endpoints & Tests

By Industry

  • Covid Impact,By Industry

  • Pharmaceuticals & Biopharmaceuticals

  • Cosmetic & Household Products

  • Food

  • Chemicals

By Technology

  • Cell Culture Technologies 

  • High-throughput Technologies 

  • Toxicogenomics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Licence Option

  • Single User-
    2500 USD 1500 USD
  • Multiple User-
    5500 USD 3500 USD

Quality assurance

A testimonial for service in the form of BBB “A” Accreditation.

Your personal and confidential information is safe and secure.

  - Information security

© 2021 Whipsmart. All Rights Reserved.

Terms of use| Site Map